Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ockelford

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Drugs|January 1, 1986
Heparin 1986. Indications and effective useP Ockelford
Australian and New Zealand Journal of Medicine|March 4, 1998
Extramedullary haematopoiesis (EMH) complicating HbE-beta thalassaemiaS Halfpenny, D Ruttenberg, P Ockelford
Internal Medicine Journal|November 18, 2004
Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?L Young, P Ockelford, P Harper
Lancet (London, England)|September 30, 1978
Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's diseaseC Menon, E W Berry, P Ockelford
Internal Medicine Journal|June 5, 2007
D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderlyP L Harper, E Theakston, J Ahmed, et al.
The New Zealand Medical Journal|October 27, 1993
Dr Jean Pierre Allain and factor VIIIE Berry, P Ockelford, L Teague, et al.
The New Zealand Medical Journal|December 10, 1999
Screening for a prothrombotic diathesis in patients attending family planning clinicsM Kalev, T Day, N Van de Water, et al.
British Journal of Haematology|February 26, 2000
Defective fibrinogen polymerization associated with a novel gamma279Ala-->Asp mutationS O Brennan, J M Wyatt, P Ockelford, et al.
Thrombosis and Haemostasis|June 3, 1998
A 20.7 kb deletion within the factor VIII gene associated with LINE-1 element insertionN Van de Water, R Williams, P Ockelford, et al.
Internal Medicine Journal|December 2, 2010
Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus locationT Prestidge, S Lee, P Harper, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Drugs|January 1, 1986
Heparin 1986. Indications and effective useP Ockelford
Australian and New Zealand Journal of Medicine|March 4, 1998
Extramedullary haematopoiesis (EMH) complicating HbE-beta thalassaemiaS Halfpenny, D Ruttenberg, P Ockelford
Internal Medicine Journal|November 18, 2004
Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?L Young, P Ockelford, P Harper
Lancet (London, England)|September 30, 1978
Beneficial effect of D.D.A.V.P. on bleeding-time in von Willebrand's diseaseC Menon, E W Berry, P Ockelford
Internal Medicine Journal|June 5, 2007
D-dimer concentration increases with age reducing the clinical value of the D-dimer assay in the elderlyP L Harper, E Theakston, J Ahmed, et al.
The New Zealand Medical Journal|October 27, 1993
Dr Jean Pierre Allain and factor VIIIE Berry, P Ockelford, L Teague, et al.
The New Zealand Medical Journal|December 10, 1999
Screening for a prothrombotic diathesis in patients attending family planning clinicsM Kalev, T Day, N Van de Water, et al.
British Journal of Haematology|February 26, 2000
Defective fibrinogen polymerization associated with a novel gamma279Ala-->Asp mutationS O Brennan, J M Wyatt, P Ockelford, et al.
Thrombosis and Haemostasis|June 3, 1998
A 20.7 kb deletion within the factor VIII gene associated with LINE-1 element insertionN Van de Water, R Williams, P Ockelford, et al.
Internal Medicine Journal|December 2, 2010
Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus locationT Prestidge, S Lee, P Harper, et al.
Pageof 3